Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells
Clinical trial NCT03274778 · WITHDRAWN
Trial details
- NCT number
- NCT03274778
- Sponsor
- Oncology Institute of Southern Switzerland
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-01
- Primary completion
- 2020-03-24
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.